Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Hematology (Amsterdam, Netherlands)
|
October 7, 2025
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase
Ehab Atallah, Michael S Broder, Onyee Chan, et al.
Blood Cancer Discovery
|
September 2, 2022
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
Anthony M Hunter, Hannah Newman, Amy E Dezern, et al.
JAMA Oncology
|
November 21, 2024
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial
Elias Jabbour, Vivian G Oehler, Paul B Koller, et al.
Blood
|
October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation
Xiaona You, Fabao Liu, Moritz Binder, et al.
Lancet Regional Health. Americas
|
June 17, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)
Brandi N Reeves, Firas El Chaer, Lynda Foltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Hematology (Amsterdam, Netherlands)
|
October 7, 2025
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase
Ehab Atallah, Michael S Broder, Onyee Chan, et al.
Blood Cancer Discovery
|
September 2, 2022
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
Anthony M Hunter, Hannah Newman, Amy E Dezern, et al.
JAMA Oncology
|
November 21, 2024
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial
Elias Jabbour, Vivian G Oehler, Paul B Koller, et al.
Blood
|
October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation
Xiaona You, Fabao Liu, Moritz Binder, et al.
Lancet Regional Health. Americas
|
June 17, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)
Brandi N Reeves, Firas El Chaer, Lynda Foltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Page
of 2